These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

122 related articles for article (PubMed ID: 1721105)

  • 21. Granulocyte transfusions for preventing infections in patients with neutropenia or neutrophil dysfunction.
    Massey E; Paulus U; Doree C; Stanworth S
    Cochrane Database Syst Rev; 2009 Jan; (1):CD005341. PubMed ID: 19160254
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Co-administration of immunomodulator tuftsin and liposomised nystatin can combat less susceptible Candida albicans infection in temporarily neutropenic mice.
    Khan MA; Nasti TH; Saima K; Mallick AI; Firoz A; Wajahul H; Ahmad N; Mohammad O
    FEMS Immunol Med Microbiol; 2004 Jul; 41(3):249-58. PubMed ID: 15196575
    [TBL] [Abstract][Full Text] [Related]  

  • 23. [Studies on defence effects of recombinant human granulocyte colony-stimulating factor (G-CSF) to infections. III. Protective effect on pulmonary and systemic infections of P. aeruginosa in neutropenic mice].
    Tomono K; Furuya N; Hirakata Y; Tateda K; Yamaguchi K; Morikawa N; Senju R; Kadota J; Kohno S; Hirota M
    Kansenshogaku Zasshi; 1990 May; 64(5):604-11. PubMed ID: 1698896
    [TBL] [Abstract][Full Text] [Related]  

  • 24. The role of colony-stimulating factors and granulocyte transfusion in treatment options for neutropenia in children with cancer.
    Liang DC
    Paediatr Drugs; 2003; 5(10):673-84. PubMed ID: 14510625
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Liposomal amphotericin B and granulocyte colony-stimulating factor therapy in a murine model of invasive infection by Scedosporium prolificans.
    Ortoneda M; Capilla J; Pujol I; Pastor FJ; Mayayo E; Fernández-Ballart J; Guarro J
    J Antimicrob Chemother; 2002 Mar; 49(3):525-9. PubMed ID: 11864953
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Phase III trial comparing granulocyte colony-stimulating factor to leridistim in the prevention of neutropenic complications in breast cancer patients treated with docetaxel/doxorubicin/cyclophosphamide: results of the BCIRG 004 trial.
    Nabholtz JM; Cantin J; Chang J; Guevin R; Patel R; Tkaczuk K; Vodvarka P; Lindsay MA; Reese D; Riva A; Mackey J
    Clin Breast Cancer; 2002 Oct; 3(4):268-75. PubMed ID: 12425755
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Recombinant murine granulocyte-macrophage colony-stimulating factor augments neutrophil recovery and enhances resistance to infections in myelosuppressed mice.
    Mayer P; Schütze E; Lam C; Kricek F; Liehl E
    J Infect Dis; 1991 Mar; 163(3):584-90. PubMed ID: 1995731
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Granulocyte colony-stimulating factor-primed leukocyte transfusions in candida tropicalis fungemia in neutropenic patients.
    Di Mario A; Sica S; Salutari P; Ortu La Barbera E; Marra R; Leone G
    Haematologica; 1997; 82(3):362-3. PubMed ID: 9234594
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Sequential administration of cyclophosphamide and granulocyte-colony stimulating factor relieves impaired myeloid maturation in Felty's syndrome.
    Pixley JS; Yoneda KY; Manalo PB
    Am J Hematol; 1993 Aug; 43(4):304-6. PubMed ID: 7690520
    [TBL] [Abstract][Full Text] [Related]  

  • 30. [Prevention and treatment of febrile neutropenia].
    Montemurro F; Gallicchio M; Aglietta M
    Tumori; 1997; 83(2 Suppl):S15-9. PubMed ID: 9235724
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Comparative effects of granulocyte-macrophage colony-stimulating factor and granulocyte colony-stimulating factor after high-dose cyclophosphamide cancer therapy.
    Bregni M; Siena S; Di Nicola M; Dodero A; Peccatori F; Ravagnani F; Danesini G; Laffranchi A; Bonadonna G; Gianni AM
    J Clin Oncol; 1996 Feb; 14(2):628-35. PubMed ID: 8636780
    [TBL] [Abstract][Full Text] [Related]  

  • 32. The efficacy of recombinant human granulocyte colony-stimulating factor and recombinant human granulocyte macrophage colony-stimulating factor in permitting the administration of higher doses of cyclophosphamide in a doxorubicin-cyclophosphamide combination. An NSABP pilot study in patients with metastatic or high-risk primary breast cancer. National Surgical Adjuvant Breast and Bowel Project.
    Mamounas EP; Anderson S; Wickerham DL; Clark R; Stoller R; Hamm JT; Stewart JA; Bear HD; Glass AG; Bornstein R
    Am J Clin Oncol; 1994 Oct; 17(5):374-81; discussion 382. PubMed ID: 7522393
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Haematopoietic growth factors as supportive therapy in HIV-infected patients.
    Hermans P
    AIDS; 1995 Dec; 9 Suppl 2():S9-S14. PubMed ID: 8775801
    [TBL] [Abstract][Full Text] [Related]  

  • 34. EORTC Cancer in the Elderly Task Force guidelines for the use of colony-stimulating factors in elderly patients with cancer.
    Repetto L; Biganzoli L; Koehne CH; Luebbe AS; Soubeyran P; Tjan-Heijnen VC; Aapro MS
    Eur J Cancer; 2003 Nov; 39(16):2264-72. PubMed ID: 14556916
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Granulocyte colony-stimulating factor and azole antifungal therapy in murine aspergillosis: role of immune suppression.
    Graybill JR; Bocanegra R; Najvar LK; Loebenberg D; Luther MF
    Antimicrob Agents Chemother; 1998 Oct; 42(10):2467-73. PubMed ID: 9756743
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Granulocyte colony-stimulating factor and other cytokines in antifungal therapy.
    Roilides E; Farmaki E
    Clin Microbiol Infect; 2001; 7 Suppl 2():62-7. PubMed ID: 11525220
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Immunotherapy in patients with systemic mycoses: a promising adjunct.
    Farmaki E; Roilides E
    BioDrugs; 2001; 15(4):207-14. PubMed ID: 11437686
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Protective effect of human granulocyte colony-stimulating factor on bacterial and fungal infections in neutropenic mice.
    Ono M; Matsumoto M; Matsubara S; Tomioka S; Asano S
    Behring Inst Mitt; 1988 Aug; (83):216-21. PubMed ID: 2467649
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Beneficial effect of recombinant human granulocyte colony-stimulating factor on fungicidal activity of polymorphonuclear leukocytes from patients with AIDS.
    Vecchiarelli A; Monari C; Baldelli F; Pietrella D; Retini C; Tascini C; Francisci D; Bistoni F
    J Infect Dis; 1995 Jun; 171(6):1448-54. PubMed ID: 7539473
    [TBL] [Abstract][Full Text] [Related]  

  • 40. A new experimental model of localized candidosis for the study of antifungal chemotherapy.
    Polak A; Schaffner A
    Mycoses; 1989 Aug; 32(8):398-404. PubMed ID: 2797055
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 7.